Thalidomide Attenuates Airway Hyperresponsiveness and Eosinophilic Inflammation in a Murine Model of Allergic Asthma
Authors:
- 1 January 2010
- journal article
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 33 (6) , 1028-1032
Abstract
Asthma is characterized by chronic eosinophilic inflammation and hyperresponsiveness of the airways. We hypothesized that thalidomide, which has numerous immunomodulatory properties, may have anti-inflammatory effects in allergic asthma. BALB/c mice sensitized and challenged with ovalbumin (OVA) were treated orally with thalidomide (30, 100, or 300 mg/kg) or a vehicle. When thalidomide was administered to OVA-challenged mice, the number of eosinophils in bronchoalveolar lavage fluid (BALF) was significantly decreased. The numbers of inflammatory cells other than eosinophils were not reduced by thalidomide. Thalidomide inhibited the elevated levels of interleukin-5 (IL-5) and tumor necrosis factor-α (TNF-α) in BALF by OVA challenges. Histological analysis of the lung revealed that both the infiltration of inflammatory cells and the hyperplasia of goblet cells were significantly suppressed by thalidomide treatment. Furthermore, thalidomide significantly inhibited the response to methacholine induced by OVA challenges. Taken together, thalidomide treatment decreased airway inflammation and hyperresponsiveness in a murine model of allergic asthma. These results might provide an opportunity for the development of novel therapeutics to treat severe asthma.Keywords
This publication has 35 references indexed in Scilit:
- IL-5- and eosinophil-mediated inflammation: from discovery to therapyInternational Immunology, 2009
- Innate Cells and T Helper 2 Cell Immunity in Airway InflammationImmunity, 2009
- Effects of Rho‐kinase inactivation on eosinophilia and hyper‐reactivity in murine airways by allergen challengesClinical & Experimental Allergy, 2007
- Suppression of Urokinase Receptor Expression by Thalidomide Is Associated with Inhibition of Nuclear Factor κB Activation and Subsequently Suppressed Ovarian Cancer DisseminationCancer Research, 2005
- Airway Remodeling in Asthma: Therapeutic Implications of MechanismsPhysiology, 2005
- ThalidomideThe Lancet, 2004
- Tumour necrosis factor‐α: The role of this multifunctional cytokine in asthmaImmunology & Cell Biology, 2001
- AsthmaNew England Journal of Medicine, 2001
- Role of IL–5 in the Development of Allergen–Induced Airway HyperresponsivenessInternational Archives of Allergy and Immunology, 1999
- Activation and Localization of Transcription Factor, Nuclear Factor- κ B, in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1998